Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002100121-26-000723
Filing Date
2026-04-29
Accepted
2026-04-29 15:21:23
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5599
  Complete submission text file 0002100121-26-000723.txt   7385
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Subject) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-86843 | Film No.: 26914952
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 VANGUARD BLVD MALVERN PA 19355
Business Address 100 VANGUARD BLVD MALVERN PA 19355 610-669-6148
VANGUARD PORTFOLIO MANAGEMENT LLC (Filed by) CIK: 0002100121 (see all company filings)

EIN.: 392888838 | State of Incorp.: PA | Fiscal Year End: 1231
LEI: 529900YN99W7NU4H6B84
Type: SCHEDULE 13G